SCHEMBL17048110

SCHEMBL17048110

CCc1cc2c3c(=O)c4ccc(C#N)cc4[nH]c3n(C(C)C)c2cc1C1CCN(C2CCOCC2)CC1

nearest known ligand 0.63

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 20/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17048109 0.97 ALK (0.65) ALK
SCHEMBL17048296 0.90 ALK (0.63) ALK
SCHEMBL18589137 0.88 ALK (0.52) ALK
SCHEMBL17054320 0.85 ALK (0.73) ALK
SCHEMBL17048161 0.85 ALK (0.66) ALK
SCHEMBL17054323 0.84 ALK (0.82) ALK
SCHEMBL17048121 0.83 ALK (0.66) ALK
SCHEMBL17048118 0.82 ALK (0.77) ALK
SCHEMBL17054295 0.82 ALK (0.64) ALK
SCHEMBL18589098 0.81 ALK (0.51) ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3110815-A1 INDOLOQUINOLONE COMPOUNDS AS ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITORS Jiangsu Ascentage Biomed Development Inc. (CN) 2017-01-04 EP disclosed
WO-2015127629-A1 INDOLOQUINOLONE COMPOUNDS AS ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITORS JIANGSU ASCENTAGE BIOMED DEVELOPMENT INC. (CN) 2015-09-03 WO disclosed